Evidence map›Paper›PMID 34317003›Full record

ArticleJACC. Case reports2020

A Long-Term Survivor With Alveolar Capillary Dysplasia.

Chandler E Yost, Angelica R Putnam, Megan K Dishop, Lynda O Jorgensen, Paul E Wirkus, Ronald W Day

Open access · goldAbstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Interstitial lung disease in the newborn.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chandler E YostUniversity of Utah, Salt Lake City, Utah.
Angelica R PutnamUniversity of Utah, Salt Lake City, Utah.
Megan K DishopPhoenix Children's Hospital, Phoenix, Arizona.
Lynda O JorgensenUniversity of Utah, Salt Lake City, Utah.
Paul E WirkusWasatch Pediatrics, Salt Lake City, Utah.
Ronald W DayUniversity of Utah, Salt Lake City, Utah.
University of Utah · USPhoenix Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering pulmonary arterial pressure and managing right heart failure. (

Indexed as

ACD, alveolar capillary dysplasiaechocardiographyiNO, inhaled nitric oxidePH, pulmonary hypertensionpulmonary hypertensionright-sided heart catheterization

Identifiers

PMID34317003
PMCPMC8302120
OpenAlexW3045883930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.